Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and ankle surgeons in the United States. The company is headquartered in Ponte Vedra Beach, Florida.
| Revenue (TTM) | $207.32M |
| Gross Profit (TTM) | $165.27M |
| EBITDA | $-47.68M |
| Operating Margin | -36.40% |
| Return on Equity | -66.90% |
| Return on Assets | -17.90% |
| Revenue/Share (TTM) | $3.25 |
| Book Value | $1.19 |
| Price-to-Book | 2.33 |
| Price-to-Sales (TTM) | 0.87 |
| EV/Revenue | 0.963 |
| EV/EBITDA | -40.95 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -10.20% |
| Shares Outstanding | $64.87M |
| Float | $48.30M |
| % Insiders | 25.25% |
| % Institutions | 57.09% |
Volatility is currently expanding